Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Santhera Pharmaceuticals Holding AG    SANN   CH0027148649

SANTHERA PHARMACEUTICALS HOLDING AG (SANN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
10/09/2018 10/10/2018 10/11/2018 10/12/2018 10/15/2018 Date
15.44(c) 15.6(c) 15(c) 15(c) 16 Last
3 325 2 313 13 828 6 096 63 325 Volume
-2.15% +1.04% -3.85% 0.00% +6.67% Change
More quotes
Financials (CHF)
Sales 2018 29,9 M
EBIT 2018 -41,5 M
Net income 2018 -25,0 M
Finance 2018 56,8 M
Yield 2018 -
Sales 2019 34,6 M
EBIT 2019 -33,1 M
Net income 2019 -9,00 M
Finance 2019 28,0 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 1,38x
EV / Sales2019 2,02x
Capitalization 97,9 M
More Financials
Company
Santhera Pharmaceuticals Holding AG is a pharmaceutical company.It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases.It offers its products under the Raxone brands.The company... 
Sector
Pharmaceuticals
Calendar
10/15Presentation
More about the company
Surperformance© ratings of Santhera Pharmaceuticals H
Trading Rating : Investor Rating :
More Ratings
Latest news on SANTHERA PHARMACEUTICALS H
10/15SANTHERA PHARMACEUTICALS : Receives Positive Opinion for Orphan Drug Designation..
GL
09/04SANTHERA PHARMACEUTICALS : Announces Financial Results for the First Half-Year 2..
GL
09/04SANTHERA PHARMACEUTICALS : Announces Financial Results for the First Half-Year 2..
AQ
08/30SANTHERA PHARMACEUTICALS HOLDING AG : half-yearly earnings release
08/23SANTHERA PHARMACEUTICALS : to Report First Half-Year Financial Figures and Provi..
AQ
08/21SANTHERA PHARMACEUTICALS : to Report First Half-Year Financial Figures and Provi..
GL
07/10SANTHERA PHARMACEUTICALS : to Present Novel Data Highlighting the Clinical Relev..
AQ
07/05SANTHERA PHARMACEUTICALS : to Present Novel Data Highlighting the Clinical Relev..
GL
06/23SANTHERA PHARMACEUTICALS : UK`s MHRA renews Early Access to Medicines Scheme Sci..
AQ
06/22SANTHERA PHARMACEUTICALS : UK's MHRA renews Early Access to Medicines Scheme Sci..
GL
More news
Sector news : Specialty & Advanced Pharmaceuticals
10/15AstraZeneca will keep UK investment freeze if no Brexit clarity
RE
10/15AstraZeneca will keep UK investment freeze if no Brexit clarity
RE
10/15BAYER : Could Outsource Some Drug Research -Reuters
DJ
10/15Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit
RE
10/15EUROPEAN PRESS ROUNDUP : Spain Plans Digital Tax, Forecaster Cuts View of U.K. G..
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
09/04Santhera Pharmaceuticals reports 1H results  
04/12Santhera Pharmaceuticals : Shareholders Approve all Board Proposals at Today'.. 
02/22Santhera Pharmaceuticals : Completes Capital Increase to Settle Obtained Lice.. 
01/29Santhera Pharmaceuticals : Reports Preliminary Key Financial Figures for 2017.. 
01/24Santhera Pharmaceuticals : Anticipates Receiving a Negative CHMP Opinion on A.. 
More tweets
Qtime:6
News from SeekingAlpha
09/05Santhera Pharmaceuticals Holdings Ltd. 2018 Q2 - Results - Earnings Call Slid.. 
09/04Santhera Pharmaceuticals reports 1H results 
04/09Mereo BioPharma Proposes Terms For U.S. IPO 
03/27Mereo BioPharma Group Files For U.S. IPO 
2017Interview - Santhera Readies Muscular Dystrophy Push 
Chart SANTHERA PHARMACEUTICALS HOLDING AG
Duration : Period :
Santhera Pharmaceuticals Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANTHERA PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Average target price 16,0  CHF
Spread / Average Target 6,7%
EPS Revisions
Managers
NameTitle
Thomas Meier Chief Executive Officer & Director
Elmar J. Schnee Chairman
Christoph Rentsch Chief Financial Officer
Kristina Sjöblom Nygren Chief Medical Officer, EVP & Head-Development
Kristina Sjoblom Nygren Chief Medical Officer & Head-Development
Sector and Competitors
1st jan.Capitalization (M$)
SANTHERA PHARMACEUTICALS HOLDING AG-58.28%99
ABBVIE-6.22%137 345
MERCK KGAA-3.89%12 886
KYOWA HAKKO KIRIN CO LTD-9.50%10 336
JAZZ PHARMACEUTICALS PLC17.95%9 386
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD42.39%7 848